Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Alixir 400 Protect
Therapeutic Area : Nephrology
Study Phase : Undisclosed
Recipient : University of Kragujevac
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Undisclosed
Product Type : Dietary Supplement
Upfront Cash : Inapplicable
December 23, 2019
Lead Product(s) : Alixir 400 Protect
Therapeutic Area : Nephrology
Highest Development Status : Undisclosed
Recipient : University of Kragujevac
Deal Size : Inapplicable
Deal Type : Inapplicable